Brinker Capital’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
$257K Sell
2,218
-27
-1% -$3.11K 0.01% 854
2020
Q1
$220K Buy
2,245
+60
+3% +$7.87K 0.01% 841
2019
Q4
$317K Sell
2,185
-60
-3% -$8.28K 0.01% 820
2019
Q3
$299K Sell
2,245
-259
-10% -$33.5K 0.01% 821
2019
Q2
$286K Sell
2,504
-57
-2% -$6.68K 0.01% 829
2019
Q1
$317K Sell
2,561
-54
-2% -$6.14K 0.01% 794
2018
Q4
$263K Sell
2,615
-1
-0% -$112 0.01% 769
2018
Q3
$334K Sell
2,616
-11
-0.4% -$1.31K 0.01% 828
2018
Q2
$284K Sell
2,627
-1,492
-36% -$162K 0.01% 881
2018
Q1
$436K Sell
4,119
-2
-0% -$232 0.02% 748
2017
Q4
$483K Buy
4,121
+1,389
+51% +$157K 0.02% 698
2017
Q3
$311K Buy
+2,732
New +$315K 0.01% 803
2017
Q2
Sell
-2,115
Closed -$251K 891
2017
Q1
$251K Buy
+2,115
New +$240K 0.01% 836

Other funds holding ZBH

Brinker Capital's ZBH Position: Q2 2020 in Review

Brinker Capital reduced its Zimmer Biomet (ZBH) stake by 1.2% in Q2 2020, selling an estimated $3.11K and leaving 2,218 shares worth $257K. The position accounts for 0.01% of the portfolio, ranked #854.

Brinker Capital first reported a position in ZBH in Q1 2017 and has held it in 13 quarters since. The position peaked at $483K in Q4 2017. 946 funds tracked by Wall St. Rank hold ZBH as of Q2 2020.

  • Brinker Capital held 2,218 shares of Zimmer Biomet worth $257K as of Q2 2020.
  • Brinker Capital sold 27 Zimmer Biomet shares in Q2 2020, an estimated $3.11K.
  • Zimmer Biomet made up 0.01% of Brinker Capital's portfolio in Q2 2020, its #854 holding.
  • Brinker Capital first reported a position in Zimmer Biomet in Q1 2017 and has held it in 13 quarters since.
  • Brinker Capital's Zimmer Biomet position peaked at $483K in Q4 2017.
  • 946 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2020.

Based on Brinker Capital's 13F filing for Q2 2020, filed 30 Jul 2020.